Caption Management, LLC Cara Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $745,745 - $1.39 Million	100,100 New	100,100 $914,000
Q4 2021 Feb 11, 2022	SELL	$11.99 - $18.14 $179,850 - $272,100	-15,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $3.4 Million - $8.02 Million	-274,900 Reduced 94.83%	15,000 $213,000
Q1 2021 May 17, 2021	BUY	$15.07 - $21.71 $3.84 Million - $5.53 Million	254,900 Added 728.29%	289,900 $6.29 Million
Q3 2019 Nov 14, 2019	SELL	$18.28 - $26.91 $3.02 Million - $4.44 Million	-165,000 Reduced 82.5%	35,000 $639,000
Q2 2019 Aug 13, 2019	BUY	$17.68 - $21.57 $3.54 Million - $4.31 Million	200,000 New	200,000 $4.3 Million
Q4 2018 Jan 30, 2019	SELL	$12.45 - $23.47 $2.49 Million - $4.69 Million	-200,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.57 - $23.95 $3.51 Million - $4.79 Million	200,000 New	200,000 $4.79 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.